- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
New Hepatitis C Therapies ; volume:34 ; number:01 ; year:2014 ; pages:007-008
Seminars in liver disease ; 34, Heft 01 (2014), 007-008
- Contributor
-
Pawlotsky, Jean-Michel
- DOI
-
10.1055/s-0034-1371178
- URN
-
urn:nbn:de:101:1-2019040811293451973274
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pawlotsky, Jean-Michel
Other Objects (12)
Stem cell therapies for autoimmune hepatitis
Immune therapies against chronic hepatitis B
Emerging therapies for the treatment of hepatitis C
Comparing drug safety of hepatitis C therapies using post-market data
New therapies in multiple myeloma
Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B
New Avenues for Nanoparticle-Related Therapies
Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
Assessing patient preferences for treatment decisions for new direct acting antiviral (DAA) therapies for chronic hepatitis C virus infections
Diabetes mellitus: new challenges and innovative therapies
Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients
Stem cell therapies for autoimmune hepatitis
Immune therapies against chronic hepatitis B
Emerging therapies for the treatment of hepatitis C
Comparing drug safety of hepatitis C therapies using post-market data
New therapies in multiple myeloma
Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B
New Avenues for Nanoparticle-Related Therapies
Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
Assessing patient preferences for treatment decisions for new direct acting antiviral (DAA) therapies for chronic hepatitis C virus infections
Diabetes mellitus: new challenges and innovative therapies
Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients
Stem cell therapies for autoimmune hepatitis
Immune therapies against chronic hepatitis B
Emerging therapies for the treatment of hepatitis C
Comparing drug safety of hepatitis C therapies using post-market data
New therapies in multiple myeloma
Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B
New Avenues for Nanoparticle-Related Therapies
Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
Assessing patient preferences for treatment decisions for new direct acting antiviral (DAA) therapies for chronic hepatitis C virus infections
Diabetes mellitus: new challenges and innovative therapies